The novel CCK antagonist L364,718 abolishes caerulein-but potentiates morphine-induced antinociception
- 1 July 1988
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 152 (1-2) , 163-166
- https://doi.org/10.1016/0014-2999(88)90849-7
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonistsJournal of Neuroscience, 1987
- Morphine action on cholecystokinin octapeptide release from rat periaqueductal grey slices: Sensitisation by naloxoneNeuropeptides, 1987
- Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist.Proceedings of the National Academy of Sciences, 1986
- Naloxone Potentiation of the Antinociceptive Action of CaeruleinaAnnals of the New York Academy of Sciences, 1985
- Cholecystokinin antagonists selectively potentiate analgesia induced by endogenous opiatesBrain Research, 1985
- Evidence for the Neuropeptide Cholecystokinin as an Antagonist of Opiate AnalgesiaScience, 1983
- A CLASSIFICATION OF OPIATE RECEPTORS THAT MEDIATE ANTINOCICEPTION IN ANIMALSBritish Journal of Pharmacology, 1980